Pharmacokinetics and pharmacodynamics of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in renal transplantation: a comparison between Japanese and non-Japanese patients

By Haba T.   Uchida K.   Katayama A.   Tominaga Y.   Sato T.   Watanabe I.   Inagaki H.   Kimata T.   Goto K.   Morozumi K.   Takeda A.   Takahara S.   Takahashi K.   Oshima S.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3174-3175

Elsevier

Access to resources Recommend Favorite

Anti-interleukin 2-receptor antibodies: a comparative study with polyclonal antibodies in kidney transplantation: preliminary results

By Martins L.   Henriques A.C.   Dias L.   Sarmento A.M.   Pereira M.C.   Guimaraes S.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2623-2625

Elsevier

Access to resources Recommend Favorite

Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizumab) in renal transplant recipients

By Nair M.P.   Nampoory M.R.N.   Johny K.V.   Costandi J.N.   Abdulhalim M.   El-Reshaid W.   Al-Muzairai I.   Ninan V.T.   Samhan M.   Al-Mousawi M.  

Transplantation Proceedings, Vol. 33, Iss. 5, 2001-08 ,pp. : 2767-2769

Elsevier

Access to resources Recommend Favorite

Results of renal transplantation with different immunosuppressive regimens

By Folkmane I.   Bicans J.   Chapenko S.   Murovska M.   Rosentals R.  

Transplantation Proceedings, Vol. 34, Iss. 2, 2002-03 ,pp. : 558-559

Elsevier

Access to resources Recommend Favorite

Evaluation of immunosuppressive induction regimens in renal transplantation

By Opelz G.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4029-4030

Elsevier

Access to resources Recommend Favorite